BENDROFLUAZIDE Side Effects

6301409-1 | Chest Pain, Contusion, Dizziness, Epistaxis, Sneezing, Thrombocytopenia, Tremor
on Jul 30, 2009 Female patient from UNITED KINGDOM , 83 years of age, was diagnosed with hypertension, angina pectoris, atrial fibrillation (What is atrial fibrillation?), benign prostatic hyperplasia and was treated with Bendrofluazide (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), contusion, dizziness (What is dizziness?), epistaxis, sneezing, thrombocytopenia, tremor. Bendrofluazide dosage: 2.5 Mg, 1x/day. During the same period patient was treated with DOXAZOSIN MESYLATE (4 Mg, 1x/day) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ACETYLSALICYLIC ACID (75 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BISOPROLOL (3.75 Mg, 1x/day) (View Bisoprolol Review and Bisoprolol Label ), FINASTERIDE (5 Mg, 1x/day) (View Finasteride Review and Finasteride Label ).

6296634-2 | Chest Pain, Contusion, Dizziness, Epistaxis, Sneezing, Thrombocytopenia, Tremor
Patient was taking Bendrofluazide (View Usage). Patient had the following side effects: chest pain (What is chest pain?), contusion, dizziness (What is dizziness?), epistaxis, sneezing, thrombocytopenia, tremor on Jul 23, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 83 years of age, was diagnosed with hypertension, angina pectoris, atrial fibrillation (What is atrial fibrillation?), benign prostatic hyperplasia and. Bendrofluazide dosage: 2.5 Mg, 1x/day. During the same period patient was treated with DOXAZOSIN MESILATE (4 Mg, 1x/day) (View Doxazosin Mesilate Review and Doxazosin Mesilate Label ), ACETYLSALICYLIC ACID (75 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BISOPROLOL (3.75 Mg, 1x/day) (View Bisoprolol Review and Bisoprolol Label ), FINASTERIDE (5 Mg, 1x/day) (View Finasteride Review and Finasteride Label ).

5604719-6 | Alveolitis Allergic
Adverse event was reported on Jan 21, 2008 by a Male patient taking Bendrofluazide (View Usage) (Dosage: ) was diagnosed with ill-defined disorder and. Location: UNITED KINGDOM , 74 years of age, weighting 172.0 lb, After Bendrofluazide was administered, patient had the following side effects: alveolitis allergic. During the same period patient was treated with PERINDOPRIL (Daily Dose: 4 Milligram(s)) (View Perindopril Review and Perindopril Label ), CALCICHEW (View Calcichew Review and Calcichew Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5336520-5 | Blood Pressure Increased
on May 16, 2007 Male patient from UNITED KINGDOM , 52 years of age, weighting 282.2 lb, was diagnosed with ill-defined disorder, hypertension, obesity (What is obesity?) and was treated with Bendrofluazide (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased. Bendrofluazide dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (Daily Dose: 8 Milligram(s)) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), XENICAL (Daily Dose: 360 Milligram(s)) (View Xenical Review and Xenical Label ).


5164710-3 | Aphagia, Areflexia, Balance Disorder, Cerebrovascular Accident, Hemiparesis
on Nov 28, 2006 Female patient from UNITED KINGDOM , weighting 198.4 lb, was diagnosed with colorectal cancer metastatic and was treated with Bendrofluazide (View Usage). Patient had the following side effects: aphagia, areflexia, balance disorder, cerebrovascular accident, hemiparesis. Bendrofluazide dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ORAMORPH SR (View Oramorph Sr Review and Oramorph Sr Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), CETUXIMAB (View Cetuximab Review and Cetuximab Label ), FLUOROURACIL (400 Mg/m2 Bolus Followed By A 46 Hour Infusion Of 2400 Mg/m2) (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

5150462-X | Cataract Operation, Dehydration, Diarrhoea, Fall, Sympathectomy
Patient was taking Bendrofluazide (View Usage). After Bendrofluazide was administered, patient had the following side effects: cataract operation, dehydration, diarrhoea, fall (What is fall?), sympathectomy on Sep 23, 2003 from UNITED KINGDOM Additional patient health information: Female patient , weighting 141.1 lb, was diagnosed with ill-defined disorder, cardiac failure congestive and. Bendrofluazide dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (Daily Dose: 4 Milligram(s)) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), GLICLAZIDE (Daily Dose: 80 Milligram(s)) (View Gliclazide Review and Gliclazide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PILOCARPINE (View Pilocarpine Review and Pilocarpine Label ). Patient was hospitalized.

4989773-7 | Intestinal Infarction
Adverse event was reported on Apr 27, 2006 by a Female patient taking Bendrofluazide (View Usage) (Dosage: ) was diagnosed with hypertension, colitis ulcerative and. Location: UNITED KINGDOM , 68 years of age, Patient experienced the following unwanted or unexpected effects: intestinal infarction. During the same period patient was treated with MESALAZINE (Daily Dose: 2400 Milligram(s)) (View Mesalazine Review and Mesalazine Label ), HYDROCORTISONE (Daily Dose: 400 Milligram(s)) (View Hydrocortisone Review and Hydrocortisone Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), LOW MOLECULAR WEIGHT HEPARIN (View Low Molecular Weight Heparin Review and Low Molecular Weight Heparin Label ).

4815691-0 | Hip Fracture
on Jul 29, 2004 Female patient from UNITED KINGDOM , weighting 154.3 lb, was diagnosed with ill-defined disorder, cardiac failure congestive and was treated with Bendrofluazide (View Usage). Patient had the following side effects: hip fracture. Bendrofluazide dosage: . During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ). Patient was hospitalized.

4815689-2 | Cataract Operation, Dehydration, Diarrhoea, Fall, Sympathectomy
on Sep 23, 2003 Female patient from UNITED KINGDOM , weighting 141.1 lb, was diagnosed with ill-defined disorder, cardiac failure congestive and was treated with Bendrofluazide (View Usage). After Bendrofluazide was administered, patient had the following side effects: cataract operation, dehydration, diarrhoea, fall (What is fall?), sympathectomy. Bendrofluazide dosage: . During the same period patient was treated with PERINDOPRIL (Daily Dose: 4 Milligram(s)) (View Perindopril Review and Perindopril Label ), GLICLAZIDE (Daily Dose: 80 Milligram(s)) (View Gliclazide Review and Gliclazide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PILOCARPINE (View Pilocarpine Review and Pilocarpine Label ). Patient was hospitalized.

4814538-6 | Acute Leukaemia, Atrial Fibrillation, Blood Pressure Systolic Increased, Chest Pain
Patient was taking Bendrofluazide (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia, atrial fibrillation (What is atrial fibrillation?), blood pressure systolic increased, chest pain (What is chest pain?) on Jan 29, 2001 from UNITED KINGDOM Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with ill-defined disorder, left ventricular failure and. Bendrofluazide dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (Daily Dose: 4 Milligram(s)) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), WARFARIN (View Warfarin Review and Warfarin Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), AMLOPIDINE (View Amlopidine Review and Amlopidine Label ). Patient was hospitalized.

4806859-8 | Erythema Multiforme, Swelling Face
Adverse event was reported on Oct 11, 2005 by a Male patient taking Bendrofluazide (View Usage) (Dosage: ) was diagnosed with ill-defined disorder, hypertension and. Location: UNITED KINGDOM , 79 years of age, Patient had the following side effects: erythema multiforme, swelling face. During the same period patient was treated with COVERSYL (Daily Dose: 2 Milligram(s)) (View Coversyl Review and Coversyl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

4595826-8 | Anaemia Haemolytic Autoimmune
on Feb 24, 2005 Female patient from , 63 years of age, weighting 138.9 lb, was diagnosed with ill-defined disorder, hypertension and was treated with Bendrofluazide (View Usage). After Bendrofluazide was administered, patient had the following side effects: anaemia haemolytic autoimmune. Bendrofluazide dosage: . During the same period patient was treated with COVERSYL (Daily Dose: 4 Milligram(s)) (View Coversyl Review and Coversyl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4568978-3 | Asthenia, Circulatory Collapse, Eye Disorder, Hot Flush
on Jan 21, 2005 Female patient from , 59 years of age, was diagnosed with ill-defined disorder, hypertension and was treated with Bendrofluazide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, circulatory collapse, eye disorder, hot flush. Bendrofluazide dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ). Patient was hospitalized.

4543814-X | Fall, Hypotension, Loss Of Consciousness
Patient was taking Bendrofluazide (View Usage). Patient had the following side effects: fall (What is fall?), hypotension, loss of consciousness on Aug 04, 2004 from Additional patient health information: Female patient , 83 years of age, was diagnosed with ill-defined disorder, hypertension and. Bendrofluazide dosage: Daily Dose: Unk.. During the same period patient was treated with COVERSYL (Daily Dose: 2 Mg.) (View Coversyl Review and Coversyl Label ), ATENOLOL (Daily Dose: Unk.) (View Atenolol Review and Atenolol Label ). Patient was hospitalized.